Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India
· Delayed Price · Currency is INR 731.20
-1.45 (-0.20%)
Mar 12, 2025, 3:30 PM IST
Aarti Pharmalabs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Net Income | - | 2,169 | 1,935 | 1,223 | -0.05 | -0.19 |
| Depreciation & Amortization | - | 732.35 | 625.43 | 421.19 | - | - |
| Loss (Gain) From Sale of Assets | - | -5.51 | 4.47 | -0.4 | - | - |
| Provision & Write-off of Bad Debts | - | 10.68 | 15 | - | - | - |
| Other Operating Activities | - | 475.51 | 237.64 | 223.3 | - | - |
| Change in Accounts Receivable | - | -1,255 | -351.72 | -1,025 | 0.05 | - |
| Change in Inventory | - | -396.64 | -1,267 | -559.92 | - | - |
| Change in Accounts Payable | - | 433.48 | 1,302 | -718.62 | - | - |
| Operating Cash Flow | - | 2,164 | 2,501 | -437.04 | - | -0.19 |
| Operating Cash Flow Growth | - | -13.50% | - | - | - | - |
| Capital Expenditures | - | -1,556 | -1,021 | -1,412 | - | - |
| Sale (Purchase) of Intangibles | - | -431.81 | -175.29 | - | - | - |
| Investment in Securities | - | -188.53 | -391.23 | -0.73 | - | - |
| Other Investing Activities | - | 30.74 | 9.77 | 24.86 | - | - |
| Investing Cash Flow | - | -2,146 | -1,578 | -1,387 | - | - |
| Short-Term Debt Issued | - | 499.94 | - | 2,723 | - | - |
| Long-Term Debt Issued | - | - | - | - | - | 0.19 |
| Total Debt Issued | - | 499.94 | - | 2,723 | - | 0.19 |
| Short-Term Debt Repaid | - | - | -1,243 | - | - | - |
| Long-Term Debt Repaid | - | -49.3 | - | - | - | - |
| Total Debt Repaid | - | -49.3 | -1,243 | - | - | - |
| Net Debt Issued (Repaid) | - | 450.64 | -1,243 | 2,723 | - | 0.19 |
| Issuance of Common Stock | - | - | - | - | - | 2.5 |
| Common Dividends Paid | - | -181.25 | -181.25 | - | - | - |
| Other Financing Activities | - | -172.15 | -210.52 | -119.59 | - | - |
| Financing Cash Flow | - | 97.24 | -1,635 | 2,604 | - | 2.69 |
| Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - | - |
| Net Cash Flow | - | 115.14 | -711.52 | 779.41 | - | 2.5 |
| Free Cash Flow | - | 607.5 | 1,480 | -1,849 | - | -0.19 |
| Free Cash Flow Growth | - | -58.95% | - | - | - | - |
| Free Cash Flow Margin | - | 3.28% | 7.61% | -15.41% | - | - |
| Free Cash Flow Per Share | - | 6.70 | 16.33 | -20.40 | - | -0.75 |
| Cash Interest Paid | - | 172.15 | 210.52 | 3.4 | - | - |
| Cash Income Tax Paid | - | 569.37 | 623.83 | 211.29 | - | - |
| Levered Free Cash Flow | - | -521.96 | 940.76 | -6,998 | - | - |
| Unlevered Free Cash Flow | - | -414.37 | 1,072 | -6,995 | - | - |
| Change in Net Working Capital | - | 1,116 | 103.46 | 7,035 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.